HR HER2 | GileadPro

Contact Register Login

HIV
Go Back

HIV

Stay up to date with educational events as well as resources for you and your patients.

HIV

BIKTARVY (bictegravir (as sodium)/ emtricitabine/ tenofovir alafenamide)

SUNLENCA (lenacapavir (as sodium))

Beyond Undetectable
Liver Diseases
Oncology
Go Back

Oncology Home

TRODELVY mTNBC

HR+/HER2- Trodelvy (sacituzumab govitecan)
Haematology
Covid-19

Contact Register Login

Home
Oncology
HR+/HER2- Trodelvy (sacituzumab govitecan)

Contact Us

Information

Contact Us
Site Map
Corporate Site

Legal

Privacy Policy
Terms of Use
Adverse Event Reporting

This website is intended for registered Australian healthcare practitioners only. GILEAD, the Gilead Logo and the Creating Possible tagline are registered trademarks of Gilead Sciences, Inc. Gilead Sciences Pty Ltd. Level 28, 385 Bourke Street Melbourne VICTORIA 3000. Telephone 03 9272 4400. Fax 03 9272 4411. Date of Preparation: January 2024. Job Number. EMVGCO0003 © 2024 Gilead Sciences, Inc. All rights reserved.

HIV

BIKTARVY (bictegravir (as sodium)/ emtricitabine/ tenofovir alafenamide)

SUNLENCA (lenacapavir (as sodium))

Beyond Undetectable

Oncology Home

TRODELVY mTNBC

HR+/HER2- Trodelvy (sacituzumab govitecan)